Summary:
Are you or a loved one currently suffering from schizophrenia?
Premier Clinical Research Institute is currently conducting a clinical research study evaluating the safety and efficacy of an investigational medication for patients with schizophrenia.
Qualified Participants Must:
• Be between the ages of 18-65
•
Have been previously diagnosed with schizophrenia for at least 1 year
Qualified Participants May Receive:
Qualified Participants Receive:
All study related exams and lab work
Investigational study medication at no cost
Complimentary transportation
No insurance necessary